Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Hedge Funds Lose Big After $CRM Slips Almost 11%

Jim Cramer told “Mad Money” viewers on October 31 that he’d rather bet with (CRM) than against them (check it out here), explaining that the cloud business is stronger than many give it credit for. Cramer’s comments came just days after T2’s Whitney Tilson told CNBC that he would be shorting CRM (read the story).

It seems Tilson was right, at least in the short term.

T2 PARTNERS shares slide more than 10% in trading on Friday after its customers billings numbers fell short of analyst estimates. New billings rose 29% during CRM’s third fiscal quarter, missing analyst estimates of 35%. CRM closed trading on Thursday at $126.09. It was trading at $112.37 a share at 3:42pm EST.

The following hedge funds lost the most:

1. Partner Fund Management – Christopher Medlock James: Lost $9.9 million

2. Conatus Capital Management – David Stemerman: Lost $6.8 million

3. Navellier & Associates – Louis Navellier: Lost $6.3 million

4. Criterion Capital – Christopher Lord: Lost $3.9 million

5. Renaissance Technologies – Jim Simons: Lost $2.8 million

6. Alkeon Capital Management – Panayotis \’takis\’ Sparaggis: Lost $2.4 million

7. Fortress Investment Group – Michael Novogratz: Lost $2.3 million

8. Adage Capital Management – Phill Gross And Robert Atchinson: Lost $2.3 million

9. Plural Investments – Matthew Grossman: Lost $2.2 million

10. Sac Capital Advisors – Steven Cohen: Lost $2.1 million

DISCLAIMER: These calculations assume that these hedge funds did not increase or reduce their stock positions in CRM since the end of June. We did not take into account their option positions.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!